NYSE:RDN
NYSE:RDNDiversified Financial

Is Radian Group (RDN) Still Attractive After Strong Multi Year Share Price Gains

Wondering if Radian Group at US$36.04 is offering good value right now or if the easy money has already been made? This article walks you through what the current price might be saying about the stock. The shares have returned 0.1% over the last 7 days, 4.9% over the last 30 days, 0.3% year to date, 17.4% over 1 year, 101.9% over 3 years and 92.2% over 5 years, which gives useful context before weighing up valuation. Recent coverage of Radian Group has focused on its position in mortgage...
NasdaqGS:VSAT
NasdaqGS:VSATCommunications

Is Viasat (VSAT) Using Evergreen’s NexusWave Deal To Quietly Redefine Its Maritime Moat?

In early January 2026, Evergreen Marine announced it had become the first Taiwanese operator to upgrade its fleet to NexusWave bonded connectivity from Inmarsat Maritime, a Viasat company, aiming to improve crew welfare, cybersecurity, and always-on vessel connectivity using the ViaSat-3 ultra-high-capacity network. This rollout highlights how Viasat’s integrated Inmarsat platform underpins data-heavy maritime applications such as predictive analytics, real-time reefer monitoring, and...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

Should BrightSpring’s Strong Earnings Beat and 14.7% Revenue Growth Require Action From BrightSpring (BTSG) Investors?

In its latest reported quarter, BrightSpring Health Services generated US$3.33 billion in revenue, a 14.7% year-on-year increase that surpassed analysts’ expectations by 5.3%, and significantly exceeded forecasts for both revenue and earnings per share. This outperformance indicates stronger-than-anticipated operational execution and demand across BrightSpring’s service lines, potentially giving investors more confidence in the company’s existing growth and margin expansion plans. Next,...
NasdaqGS:CHKP
NasdaqGS:CHKPSoftware

A Look At Check Point Software Technologies (CHKP) Valuation After New Apono Zero Standing Privilege Integration

Apono’s new integration with Check Point Software Technologies (CHKP) introduces a SASE-based Zero Standing Privilege model that focuses on temporary, task specific access in cloud environments, which could matter for investors watching Check Point’s security portfolio. See our latest analysis for Check Point Software Technologies. Against this backdrop, Check Point’s share price sits at US$190.76, with a 1-day share price return of 0.63% and a year to date share price return of 5.37%. Its 3...
NYSE:CNK
NYSE:CNKEntertainment

A Look At Cinemark Holdings (CNK) Valuation After Record 2025 Domestic Box Office Performance

Cinemark Holdings (CNK) has drawn fresh attention after reporting its highest domestic box office in 2025 since the pandemic began, with results surpassing both its own 2023 levels and the wider North American industry. See our latest analysis for Cinemark Holdings. Even with the recent box office headlines and brand tie ups like the National Popcorn Day promotion with Lowe's, Cinemark's share price has eased, with a 30 day share price return of 7.26% and a 1 year total shareholder return of...
NYSE:BDC
NYSE:BDCElectronic

Should Belden’s (BDC) New Chief Digital and Operations Role Prompt Investor Reassessment of Its Strategy?

Belden Inc. recently appointed Brad Dineley, formerly Vice President of Operations Excellence at TE Connectivity, as Executive Vice President Chief Digital and Operations Officer, reporting directly to the CEO from January 5, 2026. This new role, with global responsibility for digital and operations, comes as Belden seeks fresh leadership to address its recent sales and earnings stagnation. We’ll now examine how Dineley’s appointment to a newly empowered digital and operations role could...
NasdaqCM:TOI
NasdaqCM:TOIHealthcare

Assessing Oncology Institute (TOI) Valuation After Mark Stolper Joins The Board

Oncology Institute (TOI) recently drew fresh investor attention after announcing that Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, joined its Board of Directors, bringing additional healthcare and public markets experience. See our latest analysis for Oncology Institute. The board appointment comes as Oncology Institute’s share price has gained momentum, with a 21.1% 7 day share price return and a strong 1 year total shareholder return, although the 5 year...
NYSE:ONON
NYSE:ONONLuxury

Is On (ONON) Quietly Recasting Its Brand Beyond Running After Its ICR 2026 Fireside Chat?

On Holding AG recently announced that CEO and CFO Martin Hoffmann took part in a fireside chat at the 2026 ICR Conference, with a live webcast and replay made available through the company’s investor relations website. This conference appearance, alongside growing interest in its expansion beyond core running into tennis, trail, lifestyle, and apparel, has sharpened focus on how the brand’s product innovation and category diversification could shape its longer-term business outlook. Next,...
NYSE:STNG
NYSE:STNGOil and Gas

Scorpio Tankers (STNG) Valuation Check After Strong Multi Year Shareholder Returns

Scorpio Tankers (STNG) has drawn fresh attention after recent trading, with the share price around $56.18 and a reported value score of 6. This has put its tanker-focused business back on many investors’ watchlists. See our latest analysis for Scorpio Tankers. The recent 7 day share price return of 10.53% adds to a year to date share price return of 13.06%. The 5 year total shareholder return above 3x suggests momentum has largely built over the long run rather than just in recent...
NYSE:BILL
NYSE:BILLSoftware

Assessing BILL Holdings (BILL) Valuation After Recent Mixed Share Price Performance

BILL Holdings (BILL) has drawn fresh attention after recent trading left the shares around $54.55, with performance mixed across different time frames and longer term returns still negative for many holders. See our latest analysis for BILL Holdings. The recent 1 day share price return of a 3.13% decline comes after a 90 day share price return of 10.56%. The 1 year total shareholder return of a 33.87% decline shows that, despite some improving momentum in recent months, longer term holders...
NYSE:UHS
NYSE:UHSHealthcare

Is Universal Health Services (UHS) Attractive After Recent Share Price Weakness?

If you are wondering whether Universal Health Services is attractively priced or looking stretched at around US$211 per share, this breakdown is designed to help you make sense of the numbers. The stock has seen mixed returns, with a 3.2% decline over the last 7 days and a 6.3% decline over the last 30 days, while still sitting on gains of 11.4% over 1 year, 46.5% over 3 years, and 62.3% over 5 years. Recent share price moves have kept Universal Health Services on the radar for investors who...
NYSE:DINO
NYSE:DINOOil and Gas

Does Piper Sandler’s Upgrade Recast HF Sinclair (DINO) as a Resilient “Mini-Large Cap” Refiner?

Piper Sandler recently upgraded HF Sinclair to Overweight, highlighting the refiner’s exposure to a tighter West Coast market and a more constructive refining backdrop for 2026. The broker framed HF Sinclair as a “mini-large cap” among smaller refiners, underscoring its perceived resilience and relative appeal within the group. We’ll now examine how this increased confidence in HF Sinclair’s West Coast refining leverage could influence the company’s broader investment narrative. Trump's oil...
NasdaqGM:KRUS
NasdaqGM:KRUSHospitality

Kura Sushi USA (KRUS) Comp Growth Slump Challenges Bullish Expansion Narrative

Kura Sushi USA (KRUS) has just opened fiscal 2026 with Q1 results that sit against a backdrop of growing scale and still thin profitability, with investors weighing its US$64.93 share price against a trailing twelve month revenue base of US$282.8 million and a net loss of US$1.9 million. Over the past year, revenue has moved from US$237.9 million in the twelve months to Q4 2024 to US$282.8 million in the twelve months to Q4 2025. Over that same period, basic EPS has shifted from a loss of...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Is It Too Late To Consider SoFi Technologies (SOFI) After A 90% One-Year Surge?

If you are wondering whether SoFi Technologies' share price still makes sense after a strong run, this article walks through what the current market price might be implying about the business. The stock last closed at US$27.72, with returns of 5.9% over 7 days, 3.3% over 30 days, 0.9% year to date and 90.5% over the past year. The 3 year return sits at a very large 417.2%, and the 5 year return at 44.7%. Recent attention on SoFi has been shaped by ongoing discussion around its role as a...
NYSE:BKD
NYSE:BKDHealthcare

Assessing Brookdale Senior Living (BKD) Valuation After Recent Share Price Momentum

What Brookdale Senior Living’s Recent Returns Say About Investor Focus Brookdale Senior Living (BKD) has drawn fresh attention after a stretch of mixed share performance, with a 0.4% decline over the past day contrasting with gains over the past week, month, and past 3 months. See our latest analysis for Brookdale Senior Living. That 0.4% one day share price dip sits against a stronger pattern, with a 30.4% 3 month share price return and a very large 1 year total shareholder return that...
NYSE:NUE
NYSE:NUEMetals and Mining

Is Nucor (NUE) Pricing Fully Reflecting Its Strong 1-Year Share Price Performance?

If you are wondering whether Nucor's current share price reflects its true worth, you are not alone. This article is built to help you make sense of what you are paying for. Nucor's stock recently closed at US$167.88, with returns of 2.9% over 7 days, 6.2% over 30 days, a 0.9% decline year to date, and 44.4% over the last year, which naturally raises questions about how much of this is already priced in. Recent market attention on Nucor has centered on its position as a major U.S. steel...
NYSE:SWK
NYSE:SWKMachinery

A Look At Stanley Black & Decker (SWK) Valuation After Earnings Beat And Softer Guidance

Stanley Black & Decker (SWK) is back in focus after reporting quarterly revenues of US$3.76b that were flat year on year, along with an earnings beat but slightly softer full year EPS guidance. See our latest analysis for Stanley Black & Decker. The results-driven rally has lifted Stanley Black & Decker’s share price to US$81.49, with a 1-day share price return of 3.56% and a 90-day share price return of 26.48%, while the 5-year total shareholder return decline of 44.50% shows longer term...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Holdings (GRAB) Valuation Check As AI Robotics Deal And AV Push Lift Market Interest

Grab Holdings (GRAB) has moved deeper into automation after acquiring Chinese AI robotics firm Infermove, adding to new logistics alliances and regulatory approval to test autonomous vehicles in Singapore, which together have lifted market attention. See our latest analysis for Grab Holdings. Despite a recent 1 month share price return of 5.24% decline and a 90 day share price return of 16.72% decline from the latest close of US$4.88, the 1 year total shareholder return of 5.40% and 3 year...
NYSE:SNDR
NYSE:SNDRTransportation

Are Cautious Analyst Updates Reframing Schneider National (SNDR) as a Freight Infrastructure Staple?

In recent days, several major Wall Street firms reiterated their views on Schneider National, with Susquehanna, Wells Fargo, B of A Securities and Citi all updating their research coverage and maintaining generally cautious-but-constructive ratings on the trucking and logistics group. These analyst moves have drawn fresh attention to Schneider as a fundamentals-focused operator with a large multimodal freight network and a track record of paying regular dividends rather than chasing...
NYSE:DY
NYSE:DYConstruction

A Look At Dycom Industries (DY) Valuation As Multi Year Fiber And Broadband Growth Story Builds

Dycom Industries (DY) is back in focus after the company paired upbeat multi‑year guidance with analyst rating reaffirmations, all tied to continued demand for fiber, data center, and rural broadband infrastructure work. See our latest analysis for Dycom Industries. That upbeat multi year outlook and recent analyst commentary come after a strong run, with the share price at US$339.68 and a 90 day share price return of 19.47%, while the 1 year total shareholder return of 89.77% points to...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Why Sirius XM (SIRI) Is Up 7.2% After Stern Deal, New CFO, Berkshire Support – And What's Next

Sirius XM Holdings recently renewed Howard Stern's contract through 2028, appointed Zachary Coughlin as chief financial officer, and continued to receive backing from major shareholder Berkshire Hathaway, which has increased its stake while the company pursues cost cuts and ad-supported streaming partnerships. Together, these moves secure marquee content, sharpen the focus on profitability, and signal institutional confidence in Sirius XM’s efforts to reshape its audio business model. We’ll...
NYSE:ABG
NYSE:ABGSpecialty Retail

Is Asbury Automotive Group (ABG) Pricing Reflect Its Cash Flow And P/E Potential?

If you are looking at Asbury Automotive Group and wondering whether the current share price reflects its true value, you are in the right place for a clear valuation checkup. The stock last closed at US$250.65, with reported returns of 7.8% over 7 days, 5.4% over 30 days, 6.8% year to date, 3.6% over 1 year, 29.5% over 3 years and 51.6% over 5 years. This gives investors some context before comparing price to value. Recent news around Asbury Automotive Group has focused on its position...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Neogen (NEOG) Returns To Quarterly Profitability Challenging Persistent Bearish Loss Narratives

Neogen (NEOG) has just put Q2 2026 under the microscope with total revenue of US$209.2 million and basic EPS of US$0.17, providing a clear snapshot of where the business sits after a stretch of heavy losses. The company has seen quarterly revenue move from US$216.9 million in Q1 2025 to US$231.3 million in Q2 2025, then US$220.98 million in Q3 and US$225.5 million in Q4 2025 before landing at US$209.2 million in Q1 2026. Over the same periods, basic EPS went from a loss of US$0.06 to losses...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Assessing Legend Biotech (LEGN) Valuation After Oppenheimer Coverage And 2026 Profitability Outlook

Legend Biotech (LEGN) moved higher after Oppenheimer initiated coverage, highlighting Carvykti’s performance compared with other CAR-T therapies and noting profitability expectations for 2026 ahead of the company’s J.P. Morgan Healthcare Conference presentation. See our latest analysis for Legend Biotech. At a share price of $23.03, Legend Biotech’s 1-day and 7-day share price returns of 1.36% and 5.93% sit against a 90-day share price return of 27.35% decline and a 1-year total shareholder...